Arix Bioscience PLC has received a notification of major holdings from Acacia Research Corporation, detailing an acquisition or disposal of voting rights. The notification, dated 24th January 2024, indicates that Merton Acquisition Holdco LLC, a wholly owned subsidiary of Acacia Research Corporation, has crossed a threshold, resulting in a total of 0% of voting rights attached to shares and 0% of voting rights through financial instruments. This marks a change from the previous notification, where 25.563559% of voting rights were held.
The notification specifies that there are no direct or indirect voting rights attached to shares and no financial instruments with similar economic effect. It also includes information about the ultimate controlling person and controlled undertakings, as well as the place of completion, which is New York, New York, USA.
The announcement, transmitted by EQS Group, concludes with the disclaimer that the issuer is solely responsible for the content. The ISIN for Arix Bioscience PLC is GB00BD045071, and the notification falls under the OAM Categories 2.3 for major shareholding notifications. The EQS News ID for this announcement is 1822383.
This notification provides insight into the changes in major holdings within Arix Bioscience PLC, offering transparency and regulatory compliance in line with the company's shareholder reporting obligations.